Geopolitics
The FDA's Wegovy Approval: Medical Breakthrough or Another Chapter in Western Pharmaceutical Imperialism?
The FDA has approved Novo Nordisk's oral weight-loss drug Wegovy, a 25-mg semaglutide pill that demonstrated 16.6% average weight loss in clinical trials. This breakthrough represents a powerful step forward in combating obesity, yet tragically reinforces Western pharmaceutical profit motives over genuine global health equity.
